Oxford Immunotec
Oxford Immunotec Nabs CE Mark for COVID-19 T-Cell Response Test
The firm said its T-cell test complements serology testing and provides a more comprehensive view of the adaptive immune response to SARS-CoV-2 infection.
Oxford Immunotec, Valneva Collaborate on COVID-19 Vaccine Study
Oxford Immunotec's T-Spot Discovery SARC-CoV-2 test will be used to assess whether Valneva's vaccine candidate induces a T-cell response.
PerkinElmer to Buy Oxford Immunotec for $591M
The deal will enable PerkinElmer to grow its infectious disease testing portfolio to include latent tuberculosis detection, it said.
Nov 5, 2019
Oxford Immunotec Q3 Revenues Grow 32 Percent
Aug 6, 2019
Oxford Immunotec Q2 Revenues Jump 18 Percent
Jul 25, 2019
Jun 28, 2019
May 9, 2019
Oxford Immunotec Q1 Revenues Jump 27 Percent
Jan 31, 2019
Nov 9, 2018